DMAC Competitors & Alternatives
Compare DiaMedica Therapeutics Inc with similar stocks in the same industry
Biotechnology
DMAC
Main Stock$6.53
Tradestie Score
51
Market Cap
$354.59M
Analyst Upside
+137.4%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.12
|
$382.04M | - | 56 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$12.40
|
$371.64M | - | 54 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$17.17
|
$354.45M | - | 57 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$45.05
|
$353.70M | - | 50 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.99
|
$341.56M | - | 52 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.35
|
$332.96M | - | 49 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.85
|
$328.62M | - | 50 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$15.90
|
$308.74M | - | 56 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$10.29
|
$304.12M | - | 52 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$20.21
|
$297.23M | - | 52 | Compare |
More DMAC Analysis
Data updated: Aug 04, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry